CYP2D6 and chlorpheniramine pharmacokinetics.

被引：0
|
作者：
Yasuda, SU [1 ]
Zannikos, P [1 ]
Young, AE [1 ]
Fried, KM [1 ]
Wainer, JW [1 ]
Woosley, RL [1 ]
机构：
[1] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P7 / P7
页数：1
相关论文
共 50 条
  • [41] Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics
    Gan, Siew Hua
    Ismail, Rusli
    Adnan, Wan Aasim Wan
    Zulmi, Wan
    MOLECULAR DIAGNOSIS & THERAPY, 2007, 11 (03) : 171 - 181
  • [42] Influence of CYP2D6 phenotype on the Pharmacokinetics-Pharmacodynamics of tramadol
    Percevault, S.
    De La Gastine, B.
    Varin, L.
    Richard, N.
    Loilier, M.
    Bleyzac, N.
    Bourguignon, L.
    Lelong-Boulouard, V.
    Goutelle, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 43 - 44
  • [43] Effect of CYP2D6 genetic polymorphisms on pharmacokinetics of tropisetron.
    Oh, D
    Kim, M
    Cho, J
    Lim, H
    Hong, K
    Chung, J
    Bae, K
    Yi, S
    Shin, S
    Jang, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P21 - P21
  • [44] Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics
    Belle, DJ
    Ernest, CS
    Sauer, JM
    Smith, BR
    Thomasson, HR
    Witcher, JW
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1219 - 1227
  • [45] Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers
    Rasmus Steen Pedersen
    Per Damkier
    Kim Brøsen
    European Journal of Clinical Pharmacology, 2006, 62 : 513 - 521
  • [46] CYP2D6 genotype and risperidone pharmacokinetics, pharmacodynamics and side effects
    Novalbos, J.
    Lopez-Rodriguez, R.
    Roman, M.
    PHARMACOGENOMICS, 2011, 12 (03) : 312 - 312
  • [47] Effects of Flos Carthami on CYP2D6 and on the Pharmacokinetics of Metoprolol in Rats
    Liu, Gaofeng
    Liu, Yan
    Liu, Rui
    Dong, Feng
    Zhang, Zhiren
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 2011 : 1 - 7
  • [48] Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype
    Molden, E
    Johansen, PW
    Boe, GH
    Bergan, S
    Christensen, H
    Rugstad, HE
    Rootwelt, H
    Reubsaet, L
    Lehne, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (03) : 333 - 342
  • [49] EFFECT OF PAROXETINE ON THE PHARMACOKINETICS OF ATOMOXETINE IN DIFFERENT CYP2D6 GENOTYPE
    Kim, S. H.
    Byeon, J. Y.
    Kim, Y. H.
    Lee, H. J.
    Lee, Y.
    Lee, Y. J.
    Kim, D. H.
    Lim, H. J.
    Lee, S. Y.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E60 - E60
  • [50] Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers
    Pedersen, Rasmus Steen
    Damkier, Per
    Brosen, Kim
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (07) : 513 - 521
12345